VIRS vs. PPH
Compare and contrast key facts about Pacer BioThreat Strategy ETF (VIRS) and VanEck Vectors Pharmaceutical ETF (PPH).
VIRS and PPH are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. VIRS is a passively managed fund by Pacer Advisors that tracks the performance of the LifeSci BioThreat Strategy Index. It was launched on Jun 24, 2020. PPH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Pharmaceutical 25 Index. It was launched on Dec 20, 2011. Both VIRS and PPH are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VIRS or PPH.
Correlation
The correlation between VIRS and PPH is 0.64, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
VIRS vs. PPH - Performance Comparison
Key characteristics
Returns By Period
VIRS
N/A
N/A
N/A
N/A
N/A
N/A
PPH
9.33%
-0.99%
-5.16%
10.55%
8.27%
4.99%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
VIRS vs. PPH - Expense Ratio Comparison
VIRS has a 0.70% expense ratio, which is higher than PPH's 0.36% expense ratio.
Risk-Adjusted Performance
VIRS vs. PPH - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Pacer BioThreat Strategy ETF (VIRS) and VanEck Vectors Pharmaceutical ETF (PPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
VIRS vs. PPH - Dividend Comparison
VIRS has not paid dividends to shareholders, while PPH's dividend yield for the trailing twelve months is around 1.83%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VIRS Pacer BioThreat Strategy ETF | 0.83% | 0.97% | 0.00% | 0.67% | 0.31% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PPH VanEck Vectors Pharmaceutical ETF | 1.83% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% | 1.71% | 2.03% |
Drawdowns
VIRS vs. PPH - Drawdown Comparison
Volatility
VIRS vs. PPH - Volatility Comparison
The current volatility for Pacer BioThreat Strategy ETF (VIRS) is 0.00%, while VanEck Vectors Pharmaceutical ETF (PPH) has a volatility of 3.70%. This indicates that VIRS experiences smaller price fluctuations and is considered to be less risky than PPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.